Evercore ISI Group Maintains In-Line on Inspire Medical Systems, Raises Price Target to $54
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a In-Line and raises the price target from $40 to $54.
Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a In-Line and raises the price target from $40 to $54.